| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calcium Research Laboratory of the McGill University Health Center (D.M., J.L., Y.X., D.G.), Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital (H.S., A.C.K.), and Department of Medicine, McGill University, Montréal, Québec, Canada
Address all correspondence and requests for reprints to: Dr. David Goltzman, Calcium Research Laboratory, Royal Victoria Hospital, 687 Pine Avenue W, Room H4.67, Montréal, Québec, Canada H3A 1A1. E-mail: david.goltzman{at}mcgill.ca.
We investigated the relative contributions of PTH and PTHrP to the skeletal phenotype of mice deficient in PTH (PTH/). PTH/ mice and PTH/ mice lacking one allele encoding PTHrP (PTH/PTHrP+/) were compared. Both mutants displayed similar biochemical abnormalities of hypoparathyroidism, but skeletal PTHrP mRNA and protein were decreased in PTH/PTHrP+/ mice. PTH/ mice had increased trabecular bone volume with diminished bone turnover. PTHrP haploinsufficiency reduced trabecular bone of the PTH/ mice to levels below those in wild-type animals by decreasing osteoprogenitor cell recruitment, enhancing osteoblast apoptosis, and diminishing bone formation. The results show that the increased trabecular bone volume in PTH-deficient mice is due to diminished PTH-induced osteoclastic bone resorption and persistent PTHrP-stimulated osteoblastic bone formation. They also illustrate the changing role of PTHrP during bone development, demonstrate its bone- forming function in the postnatal state, and support its pharmacological potential as an anabolic agent.
This article has been cited by other articles:
![]() |
C. Galli, L. A. Zella, J. A. Fretz, Q. Fu, J. W. Pike, R. S. Weinstein, S. C. Manolagas, and C. A. O'Brien Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Reduces Bone Remodeling and Increases Bone Mass Endocrinology, January 1, 2008; 149(1): 146 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fuentes, P. M. Guerreiro, T. Modesto, J. Rotllant, A. V. M. Canario, and D. M. Power A PTH/PTHrP receptor antagonist blocks the hypercalcemic response to estradiol-17beta Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R956 - R960. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gao, R. Tiwari-Pandey, R. Samadfam, Y. Yang, D. Miao, A. C. Karaplis, M. R. Sairam, and D. Goltzman Altered Ovarian Function Affects Skeletal Homeostasis Independent of the Action of Follicle-Stimulating Hormone Endocrinology, June 1, 2007; 148(6): 2613 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Samadfam, Q. Xia, and D. Goltzman Pretreatment with Anticatabolic Agents Blunts But Does Not Eliminate the Skeletal Anabolic Response to Parathyroid Hormone in Oophorectomized Mice Endocrinology, June 1, 2007; 148(6): 2778 - 2787. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xue, A. C. Karaplis, G. N. Hendy, D. Goltzman, and D. Miao Exogenous 1,25-Dihydroxyvitamin D3 Exerts a Skeletal Anabolic Effect and Improves Mineral Ion Homeostasis in Mice that Are Homozygous for Both the 1{alpha}-Hydroxylase and Parathyroid Hormone Null Alleles Endocrinology, October 1, 2006; 147(10): 4801 - 4810. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, S. C. Manolagas, and C. A. O'Brien Parathyroid Hormone Controls Receptor Activator of NF-{kappa}B Ligand Gene Expression via a Distant Transcriptional Enhancer. Mol. Cell. Biol., September 1, 2006; 26(17): 6453 - 6468. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling Development, January 1, 2006; 133(1): 63 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xue, A. C. Karaplis, G. N. Hendy, D. Goltzman, and D. Miao Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development Hum. Mol. Genet., June 1, 2005; 14(11): 1515 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bisello, M. J. Horwitz, and A. F. Stewart Parathyroid Hormone-Related Protein: An Essential Physiological Regulator of Adult Bone Mass Endocrinology, August 1, 2004; 145(8): 3551 - 3553. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |